This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Roche's petition against generic 'Risdiplam' dismissed by India's top court

By Freny Patel ( October 17, 2025, 10:11 GMT | Insight) -- Roche lost its bid at India's top court to halt Natco Pharma from selling a drastically cheaper generic of the SMA drug, Risdiplam, until a trial on a patent infringement suit is decided. Handing down its ruling, the Supreme Court of India on Friday said it will not interfere with the high court ruling. F Hoffmann-La Roche, suffered a setback as India's top court dismissed the Swiss pharmaceutical giant's petition to block Natco Pharma from manufacturing and selling the generic version of Risdiplam....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections